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OBJECTIVES We sought to evaluate whether a limited surgical cryoablation of the posterior region of the
left atrium was safe and effective in the cure of atrial fibrillation (AF) in patients with
associated valvular heart disease.
BACKGROUND Extensive surgical ablation of AF is a complex and risky procedure. The posterior region of
the left atrium seems to be important in the initiation and maintenance of AF.
METHODS In 32 patients with chronic AF who underwent heart valve surgery, linear cryolesions
connecting the four pulmonary veins and the posterior mitral annulus were performed.
Eighteen patients with AF who underwent valvular surgery but refused cryoablation were
considered as the control group.
RESULTS Sinus rhythm (SR) was restored in 25 (78%) of 32 patients immediately after the operation.
The cryoablation procedure required 20 6 4 min. There were no intraoperative and
perioperative complications. During the hospital period, one patient died of septicemia.
Thirty-one patients reached a minimum of nine months of follow-up. Two deaths occurred
but were unrelated to the procedure. Twenty (69%) of 29 patients remained in SR with
cryoablation alone, and 26 (90%) of 29 patients with cryoablation, drugs and radiofrequency
ablation. Three (10%) of 29 patients remained in chronic AF. Right and left atrial
contractility was evident in 24 (92%) of 26 patients in SR. In control group, two deaths
occurred, and SR was present in only four (25%) of 16 patients.
CONCLUSIONS Linear cryoablation with lesions connecting the four pulmonary veins and the mitral annulus
is effective in restoration and maintenance of SR in patients with heart valve disease and
chronic AF. Limited left atrial cryoablation may represent a valid alternative to the maze
procedure, reducing myocardial ischemic time and risk of bleeding. (J Am Coll Cardiol 2000;
36:159–66) © 2000 by the American College of Cardiology
Atrial fibrillation (AF) is the most frequent supraventricular
arrhythmia, and its pharmacologic therapy is not always
satisfactory. However, it has been shown that a radical cure
of AF might be possible. Cox et al. (1–4) were the first
investigators who successfully treated AF using the maze
procedure, which consisted of an extensive dissection with
compartmentalization of both atria. Although effective, this
long operation is rather complex and causes severe damage
to the atria. Therefore, this procedure is not routinely used
to cure AF in patients undergoing cardiovasculary surgery.
Recently, a catheter ablation technique mimicking the
maze procedure has been proposed. Despite a relatively high
success rate, it has a significant risk of complications (5–7).
Moreover, catheter ablation of atrial foci localized in the
pulmonary veins, which trigger AF, has been shown to be
effective (8), but it is still limited to those patients with
paroxysmal AF.
The possibility of performing selective ablation has sev-
eral advantages, such as less atrial damage and, conse-
quently, better preserved atrial mechanical function, shorter
procedure time and less risk of related complications.
Previous studies in animals (9,10) and humans (11) have
shown that ablation of limited atrial areas may be effective in
the cure of AF. Few data available on left atrial mapping
showed that the posterior wall seems to be a critical area for
the maintenance of AF in patients with valvular heart
disease (12). On the basis of these considerations, we
decided to evaluate the effectiveness of linear cryoablation
confined only to the posterior region of the left atrium
between the pulmonary veins and the mitral annulus.
Cryoablation has been successfully used for over two
decades in the surgical treatment of cardiac arrhythmias. It
has been shown that cryoablation creates more homoge-
neous lesions and, above all, leaves the atrial endocardium
intact (7,13). This may be important, especially in the future
endeavors to reproduce such lesions with a transvenous
catheter approach, because it could significantly reduce the
risk of thromboembolism, which, at present, is the worst
complication related to the extensive endocardial damage
created by multiple radiofrequency (RF) deliveries.
Therefore, the objective of this study was to evaluate
whether a limited surgical cryoablation of the posterior
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region of the left atrium was safe and effective in the cure of
chronic AF in patients who also had valvular heart disease.
METHODS
Study group. The study group included 32 patients with
chronic AF undergoing heart valve surgery owing to mitral
or aortic valve disease, or both. Written, informed consent
was required from all patients before the operation. Table 1
shows the patients’ clinical characteristics in detail. The
mean duration of AF was 6.1 6 5.2 years. In 9% of patients,
previous systemic embolization was reported. In the major-
ity of patients, the mitral valve was diseased, only 6% being
purely aortic. A cardiac reintervention was performed in
16% of patients.
Eighteen consecutive patients with chronic AF who were
matched for age, AF duration and heart valve disease treated
with valve surgery, but who refused the cryoablation proce-
dure, were selected and considered as the control group.
Surgical procedure and cryoablation. All operations were
performed by the same surgeon, under routine cardiopul-
monary bypass with double venous cannulation and mod-
erate hypothermia. The left atrium was opened through the
usual left paraseptal incision after cold cardioplegic arrest.
The left appendage, when present, was externally ligated at
this moment. Once inspection of the mitral and/or aortic
valves had been completed and the valve was repaired or
removed, cryoablation was started.
A dual-probe cardiac cryosurgical system (Frigitronics,
Cooper Surgical, Shelton, Connecticut) was used. The
pressure in the two cylinders containing nitrous oxide
(N2O) was always maintained above 720 psi (pounds per
square inch). The temperature fell abruptly to 260°C at the
probe tip when gas was delivered and then maintained for
2 min. The two probes were used simultaneously, close to
each other, to cut in half the duration and to not leave any
gap between applications, as the acute endocardial lesion is
not visible. Cryoablation was performed following the path
counterclockwise (Fig. 1).
Finally, a mitral or aortic prosthesis was inserted, if
required, and the operation continued as usual. At the end
of extracorporeal circulation, adrenaline (0.025 gamma/kg
Abbreviations and Acronyms
AF 5 atrial fibrillation
ECG 5 electrocardiogram or electrocardiographic
RF 5 radiofrequency
SR 5 sinus rhythm
Figure 1. Schema of the procedure. The four pulmonary veins were
isolated and the left atrial appendage was excised. The lesion lines
connected the four pulmonary veins and the right and left lower pulmonary
veins to the posterior mitral annulus.
Table 1. Clinical Characteristics of Study Group
Patients With
Cryoablation
(n 5 32)
Patients Without
Cryoablation
(n 5 18) p Value
Gender (M/F) 14/18 3/15 NS
Age (years) 62 6 10 68 6 8 NS
NYHA class II 4 (13%) 3 (17%) NS
NYHA class III 27 (84%) 14 (78%) NS
NYHA class IV 1 (3%) 1 (5%) NS
AF duration (years) 6.1 6 5.2 6.9 6 4.3 NS
LA diameter (mm) 52.5 6 6.5 52.9 6 6.2 NS
Underlying valve disease
Mitral stenosis 9 (28%) 4 (22%) NS
Mitral regurgitation 7 (23%) 2 (11%) NS
Mitral stenosis and regurgitation 11 (34%) 4 (22%) NS
Aortic stenosis 1 (3%) 2 (11%) NS
Aortic stenosis and regurgitation 1 (3%) 2 (11%) NS
Mitral plus aortic 3 (9%) 4 (22%) NS
Previous embolic episodes 3 (9%) 2 (11%) NS
Reoperation 5 (16%) 3 (17%) NS
Data are presented as the number (%) of patients or mean value 6 SD.
AF 5 atrial fibrillation; F 5 female; LA 5 left atrium; M 5 male; NS 5 not significant; NYHA 5 New York Heart
Association functional class.
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body weight per min) was administered to all patients.
Intraoperative direct current cardioversion was routinely
performed in all patients who had AF. Amiodarone infusion
(150-mg loading dose over 10 to 15 min; then 1 mg/min for
6 h; then 0.5 mg/min until oral administration) was started
after weaning from bypass, regardless of the heart rate or
rhythm.
To assess whether the damage caused by exposure of the
atrial endocardium to freezing was transparietal, an atrial
biopsy was performed after cryoablation in eight patients at
the beginning of our study.
Postoperative management and follow-up. During the
hospital period, patients in both the AF/cryoablation and
control groups were monitored by continuous electrocardi-
ography. After intravenous infusion, oral amiodarone
(600 mg/day for 10 days; then 400 mg/day for 10 days; then
200 mg/day) was administered to all patients, except for one
in whom propafenone (300 mg twice a day) was preferred
because of previous dysthyroidism. Antiarrhythmic therapy
was routinely withdrawn after three months in the absence
of AF recurrence. During the hospital stay, an attempt at
electrical cardioversion was performed in all patients with
AF.
After discharge, the patients were followed up with a
clinical examination and electrocardiographic (ECG) and
Holter monitoring at 1, 3, 6, 9, 12 and 18 months. In case
symptoms recurred between follow-up visits, a clinical
examination and ECG and Holter monitoring were per-
formed and an event recorder was applied. Doppler echo-
cardiography, with evaluation of transtricuspid and trans-
mitral flow, was performed before discharge and at three
and six months after the operation. After three months, oral
anticoagulant therapy was discontinued in patients under-
going valvuloplasty who were in sinus rhythm (SR) with the
presence of atrial contraction documented by Doppler
echocardiography.
Statistical analysis. Continuous variables are expressed as
the mean value 6 SD. To compare outcomes, survival
analysis and the log-rank test were used. Categoric variables
were compared by using the chi-square test or the Fisher
exact test, when appropriate. Results were considered to be
statistically significant at p , 0.05. Statistical analysis was
performed using the “Statistics” software (StatSoft Inc.,
Tulsa, Oklahoma).
RESULTS
Surgical procedure. Operative data are listed in Table 2.
The mean aortic clamping time and extracorporeal circula-
tion times were 20 and 21 min, respectively, longer than
those times in the control group, reflecting the mean
duration of the cryoablation procedure. Among patients
with AF/cryoablation, a bioprosthesis was employed in six
(19%) and valvuloplasty was performed in another eight
(25%).
In the group of patients with AF/cryoablation, SR was
restored in 25 patients (78%), either spontaneously or after
intraoperative direct current cardioversion, immediately af-
Table 2. Operation and Early Postoperative Data
Patients With
Cryoablation
(n 5 32)
Patients Without
Cryoablation
(n 5 18) p Value
Operation data
MV replacement 20 (63%) 8 (45%) NS
AV replacement 3 (9%) 4 (22%) NS
MV plus AV replacement 1 (3%) 4 (22%) NS
MV, plastic 8 (25%) 2 (11%) NS
Bioprostheses 6 (19%) 2 (11%) NS
Associate CABG 5 (16%) 1 (6%) NS
ECC time (min) 84 6 18 63 6 21 0.001
ACC time (min 68 6 17 48 6 20 0.001
IABP 1 (3%) 0 NS
Rhythm outcome
SR 25 (78%) 4 (22%) , 0.001
AF 5 (16%) 14 (78%) , 0.001
Junctional rhythm 2 (6%) 0 NS
Temporary pacemaker 12 (38%) 6 (33%) NS
Early postoperative data
Hospital stay (days) 7 6 4 6 6 2 NS
Direct current cardioversion 12 (37%) 17 (94%) , 0.005
Revision bleeding 1 (3%) 0 NS
Revision valvular leak 1 (3%) 0 NS
Permanent pacemaker 1 (3%) 0 NS
Death 1 (3%) 1 (6%) NS
Data are presented as the number (%) of patients or mean value 6 SD.
ACC 5 aortic cross-clamp; AF 5 atrial fibrillation; AV 5 aortic valve; CABG 5 coronary artery bypass graft surgery;
ECC 5 extracorporeal circulation; IABP 5 intra-aortic balloon pump; MV 5 mitral valve; NS 5 not significant; SR 5 sinus
rhythm.
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ter the operation, as compared with four patients (22%) in
the control group (p , 0.001). There were no intraoperative
or perioperative complications. Inotropes were used in all
patients in the immediate postoperative period both in the
AF/cryoablation group and the control group. High doses
of intravenous inotropes were used in three patients (9%)
with postoperative low cardiac output syndrome in the
AF/cryoablation group: one patient was in SR; the second
one had AF; and the third one was in junctional rhythm.
Also, in two patients in the control group, a high dose of
intravenous inotropes were used. Both patients had AF.
Atrial biopsies performed after cryoablation in eight patients
revealed morphologic features indicating irreversible injury,
such as nuclear and cytoplasmic degenerative lesions with no
viable cardiomyocytes. The lesions involved the full thick-
ness of the wall (Fig. 2).
Early postoperative period. Table 2 shows in detail the
early postoperative data in patients with AF/cryoablation
and in control subjects. The mean hospital stay was 7 6
4 days (range 5 to 22) in patients with AF/cryoablation.
There was no significant statistical difference in the hospital
stay between patients with AF/cryoablation and control
subjects. The number of direct current cardioversions per-
formed was higher in the control group.
In the AF/cryoablation group, one patient (3%) had
another operation within one week due to periprosthetic
leakage. There was one in-hospital death (3%) because of
septicemia occurring three weeks after the operation. This
patient was in SR. In one patient (3%) with AF, a
permanent pacemaker (VVI) was implanted because of
symptomatic bradycardia.
Twenty-three (74%) of 31 patients with AF who under-
went cryoablation were in SR at the time of hospital
discharge.
In the control group, one patient died from heart failure
the day after the operation. Among the remaining
Figure 2. The photomicrograph shows nuclear changes (arrow pointing
left), irregular bands of contraction (arrow pointing right) and indistinct
membranes (star) (Hematoxylin-eosin 3 400)
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17 patients, only two (12%) were in SR at the time of
discharge, despite attempts at electrical cardioversion.
Follow-up. In the cryoablation group at three-month
follow-up, 27 (87%) of 31 patients were in SR. Among
these patients, 21 (68%) with treated with cryoablation only.
Four patients (13%) had a few episodes of paroxysmal AF
during the first three months, but they maintained SR
during the remaining follow-up period. All four patients
received antiarrhythmic drugs: two received amiodarone and
two received propafenone.
Two patients (6%) were in SR with episodes of paroxys-
mal atrial tachycardia. Both patients underwent an electro-
physiologic study with a nonfluoroscopic mapping system
(CARTO, Biosense-Webster). In one patient, the mapping
revealed a pattern of radial activation modified by interven-
ing scar tissue, resembling a pattern of perimitral reentry. A
single application of RF energy at the site of earliest
activation was effective in eliminating the tachycardia,
suggesting a focal mechanism. In the second patient, the
atrial mapping did not determine the tachycardia mecha-
nism. Neither entrainment nor RF energy application be-
tween the right inferior pulmonary vein and the mitral
annulus, where a gap was present, further clarified the
nature of the atrial tachycardia. The patient underwent
electrical cardioversion with restoration of normal SR, and
sotalol therapy (80 mg twice a day) was initiated. No further
episodes of atrial tachycardia or AF were detected in both
patients.
All patients reached a minimum of nine months of
follow-up, during which two deaths occurred. One patient
with chronic AF died of heart failure four months after the
operation, and the other one in SR died of intracerebral
hemorrhage after seven months of follow-up. The patient
was not taking anticoagulant agents because of a biopros-
thesis.
Of the remaining 29 patients, 26 were in SR at nine
months. Of these patients, 20 (69%) were in SR and had
cryoablation alone; 21 (73%) had cryoablation and RF
ablation; and 26 (90%) had cryoablation and RF ablation
and took antiarrhythmic drugs (Fig. 3).
This trend was maintained at 12 months, at which time
18 (90%) of 20 patients remained in SR with cryoablation,
RF ablation and antiarrhythmic drugs.
After the cryoablation procedure, 12 patients, including
the aforementioned two patients with episodes of atrial
tachycardia, underwent an electrophysiologic study, which
did not show fibrillation in any part of the left atrium.
Table 3 shows the characteristics of cardiac rhythm in
patients with AF/cryoablation at discharge and 1, 3, 6, 9
and 12 months.
In the control group at three-month follow-up, one death
occurred from heart failure. In the remaining 16 patients,
four (25%) were in SR: two who took an antiarrhythmic
drug and two who did not. Two patients were discharged in
SR that was maintained during follow-up. In two patients,
electrical cardioversion was successful one month after the
operation and no more episodes of AF were detected. The
remaining 12 patients (75%) had chronic AF. This trend
was consistent at 6, 9 and 12 months of follow-up (Fig. 3).
The difference in outcome between the two groups was
statistically significant during follow-up (p , 0.0001) (Fig.
4).
When comparing patients in SR with those with AF after
cryoablation, no statistically significant difference was seen
regarding the patients’ age, right and left atrial size, type of
surgical procedure and duration of extracorporeal circulation
and aortic clamping time. The difference in duration of AF
was not statistically significant, but it was longer than 10
years in three of four patients who still had chronic AF at
the end of follow-up (188, 144 and 132 months, respective-
ly).
Among patients with AF who underwent cryoablation,
one in SR had another operation for mitral valvuloplasty
failure one month later; interestingly, during the second
operation, no evidence of the cryoablation lesions was
present on gross inspection of the endocardium. Another
patient required implantation of a dual-chamber permanent
pacemaker because of symptomatic sinus bradycardia four
months after the initial procedure.
Doppler echocardiography revealed the presence of right
and left atrial contractility in 24 (92%) of the 26 patients in
SR.
DISCUSSION
Major findings. There were three major findings from this
study: 1) The creation of a few linear cryolesions in the
posterior region of the left atrium in patients with chronic
AF undergoing heart valve surgery is effective in restoration
Figure 3. Follow-up results. Bar graph shows the number of patients in
SR, expressed as percentage, in the AF/cryoablation group and in the
control group at nine-month follow-up. Control alone 5 control subjects
with no antiarrhythmic drugs; control total 5 control subjects with and
without antiarrhythmic drugs; cryo alone 5 patients with cryoablation
only; cryo 1 RFA 5 patients with cryoablation and RF ablation; cryo
total 5 patients with cryoablation, RF ablation and antiarrhythmic drugs.
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and maintenance of SR, allowing for the recovery of atrial
function in the majority of the patients. 2) Our procedure
has proved to be feasible and requires only a little extra time
to the heart valve surgery time (;20 min). 3) The atrial
linear lesions created by cryoablation during cardiac surgery
have shown to be safe.
Electrophysiologic background. It is generally accepted
that the electrophysiologic substrate responsible for the
maintenance of AF is the presence of multiple, simulta-
neous reentrant waves circulating through the atrial tissue
(14,15). The surgical maze procedure divides the atrial
myocardium into multiple, small segments, thus reducing
the mass of tissue electrically activated and impeding the
multiple wavelets of reentry to be sustained.
However, several recent reports (9,11,16,17) have shown
that different patterns of electrical activity in various atrial
regions are present during AF, with the simultaneous
presence of regions with relatively regular activation and
other areas with completely disorganized atrial activity.
These studies suggested that the fibrillatory process is far
from random and seems to be significantly influenced by
anatomic and electrophysiologic factors. Therefore, al-
though the atria, as a whole, participate in the process of
AF, not all the atrial regions contribute equally to the
perpetuation of fibrillation. This hypothesis also seems to be
corroborated by the success of selective ablation of critical
areas reported in some cases (9,11). Many studies point to
the importance of the posterior region of the left atrium as
a critical area in the maintenance of AF, both in animals (9)
and humans (6,8,12,18). Morillo et al. (9) showed that in
dogs, the shortest FF intervals during AF were recorded in
the left posterior wall. Cryoablation limited to this zone was
effective in terminating and preventing reinduction of the
arrhythmia in 82% of cases. Sueda et al. (12) showed that in
patients with chronic AF and mitral valve disease, the areas
with the shortest FF intervals were at the base of the left
atrial appendage and the posterior wall lateral to the left
pulmonary veins. Furthermore, they demonstrated that the
surgical isolation of these areas restored SR in most patients.
The importance of the left atrium in the maintenance of AF
is also confirmed by reports on percutaneous catheter
ablation of AF (5,6,8), showing a higher success rate when
linear lesions were applied within the left atrium. However,
the safety of a procedure that includes extensive ablation of
the left atrium has not been sufficiently demonstrated, and
severe complications, such as cardiac tamponade or throm-
boembolism, have been reported (5–7). This risk of severe
complications encourages us to limit the ablation areas as
much as possible. Identifying localized atrial regions respon-
sible for the initiation and maintenance of AF would be
crucial for a safe and effective ablation procedure.
Recently, Haissaguerre et al. (8) showed that in patients
with idiopathic AF, the pulmonary veins represent impor-
tant areas in triggering and maintaining AF, and RF
ablation limited to these areas was successful in a high
percentage of cases.
In our study, using cryoenergy, we performed linear
lesions connecting the four pulmonary veins and the inferior
pulmonary veins to the posterior mitral annulus with the
purpose of isolating this area. Our results confirmed the
critical role of the posterior region of the left atrium. It is
still not possible to establish whether the restoration of SR
depends on the modification of the substrate of AF by the
linear lesions or whether it is due to the isolation or
elimination of potential focal triggers within the pulmonary
veins, or a combination of both mechanisms.
In contrast, we should consider that the creation of linear
lesions, especially incomplete ones, may represent a sub-
strate for the occurrence of new intra-atrial tachycardias
whose mechanism is difficult to establish.
Comparison with previous studies. Over the last decade,
several reports have presented different surgical techniques
Figure 4. Difference in outcome between the AF/cryoablation group and the control group during follow-up. Cryo total 5 patients with cryoablation, RF
ablation and antiarrhythmic drugs; control total 5 control subjects with and without antiarrhythmic drugs.
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to cure AF (1–4,12,18,19–21). The corridor operation was
the first one to show that operation may control AF (19). It
consists of isolating a strip of atrial tissue (corridor) that
harbors the sinus node and the atrioventricular node. It was
observed that the left atrium remained in AF, pointing to
the importance of the left atrium in the genesis of AF.
Graffigna et al. (21) have reported that 71% of patients with
mitral valve disease returned to SR after left atrial isolation.
With these surgical approaches the problem is the persis-
tence of AF in the left atrium or part of it leaving the
hemodynamic and thromboembolic problems unresolved.
The maze procedure was shown to be effective in eliminat-
ing AF and restoring atrial contractility in the majority of
patients (1–4). In a long-term follow-up study, the maze
procedure had a success rate of 93% for restoration of SR,
without use of antiarrhythmic drugs, in a population mostly
characterized by idiopathic AF (3). Kosakai et al. (20)
reported that the maze procedure was effective in maintain-
ing SR also in patients with organic heart disease, even if
;30% of patients did not present with left atrial contraction
during follow-up. However, the maze procedure is time-
consuming and requires an intricate pattern of atrial inci-
sions, extensive suturing, relevant blood loss and a pro-
longed cardiopulmonary bypass.
With the aim of minimizing blood loss and reducing the
cardiopulmonary bypass time, Chen et al. (22) have simu-
lated the classic maze operation in 12 patients undergoing
mitral valve surgery by using the combination of RF catheter
ablation and cryoablation instead of extensive atrial surgical
incisions. They reported that at the end of six-month
follow-up, SR was restored in 60% of patients, but only 30%
of patients showed left atrial contractility. Recently, Sueda
et al. (12,18) developed a surgical procedure mainly involv-
ing the posterior wall of the left atrium for treatment of
chronic AF associated with mitral valve disease. They
reported a disappearance of AF at six months after the
operation in 78% of patients, with recovery of left atrial
contractility in 61% of patients.
In our study, we chose to limit the part of the left atrium
involved in the procedure as much as possible to reduce the
time of the operation and to preserve normal atrial contrac-
tility, and we used only cryoenergy to perform the linear
lesions. During follow-up, we observed restoration of SR in
90% of the patients. In 69% of patients, cryoablation alone
was sufficient to maintain normal SR; one patient also
required RF ablation of atrial tachycardia; and five patients
also had pharmacologic therapy. The early success of the
cryoablation procedure is predictive of long-term efficacy.
The proarrhythmic effect related to the cryoablation scar,
although present, appears to be minimal, and in some cases
can be resolved with RF ablation. We have not found
variables predictive of failure, but we noticed that in patients
who still had chronic AF after the cryoablation procedure, a
long AF duration (.10 years) was evident in three of four
patients. Most important, the majority of the patients (92%)
in SR showed restored right and left atrial contractility.
Furthermore, the procedure required only 20 min, and the
aortic cross-clamp time and cardiopulmonary bypass times
were very short in comparison with those in previous studies
(1,4,18,20,22). This significant reduction of myocardial
ischemic time may allow us to perform this procedure
routinely in patients with AF undergoing heart valve sur-
gery.
Potential advantages of cryoablation. The risk of throm-
boembolic complications in patients undergoing multiple
linear lesions in the left atrium using RF energy is high
(5,7). We chose to deploy cryothermy as an alternative
energy source to create linear lesions for two reasons.
First, cryoablation has the advantage of leaving the
endocardium intact (7,13,23), thus reducing the throm-
boembolic risk, as demonstrated by most of the data on
surgical cryoablation (7,24,25) as well as by experimental
studies (13,23,26,27). Second, the lesion created by
cryoablation has been demonstrated to be transmural and
well circumscribed. The chronic scar is made of dense
fibrotic tissue without viable cardiomyocytes, with no
tendency to rupture or dilate, because cryoablation in-
duces necrosis of myocardial tissue but spares the collag-
enous fiber (13,25–27), as confirmed by our histologic
data. In contrast, the lesions produced with RF energy
are less circumscribed and nonhomogeneous, with clear
evidence of viable cardiomyocytes, and, most important,
this energy causes endocardial disruption with a conse-
quent potential risk of a thromboembolic event (13).
Clinical implications. The study shows that cryoablation,
creating linear lesions connecting the four pulmonary veins
and the inferior pulmonary veins to the mitral annulus in
patients with chronic AF and valvular heart disease, is
effective. Moreover, the procedure is simpler and faster,
with less atrial damage, than the maze operation.
These data are important if we consider that elimination
of AF and maintenance of atrial contractility provide he-
modynamic benefit, especially in patients with associated
heart disease; moreover, the use of anticoagulant therapy
may be avoided in those patients who undergo valvuloplasty
or a bioprosthesis operation.
Furthermore, these data may also be used for the repro-
duction of the same type of lesions using percutaneous
catheter ablation in patients with chronic AF with or
without associated heart disease, avoiding the need of open
heart surgery and related complications.
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